INITIAL PUBLIC OFFERING AND SEPARATION ACTIVITIES

12 Months Ended

Dec. 31, 2011

INITIAL PUBLIC OFFERING AND SEPARATION ACTIVITIES

INITIAL PUBLIC OFFERING AND SEPARATION ACTIVITIES

2. INITIAL PUBLIC OFFERING AND SEPARATION ACTIVITIES

        On February 17, 2009, Mead Johnson Nutrition Company completed the initial public offering (IPO) of 34.5 million shares common stock at a price of $24.00 per share. Prior to and immediately following the IPO, 170.0 million shares of common stock were owned by Bristol-Myers Squibb Company (BMS). The net proceeds from the IPO, after deducting a total of $45.7 million of underwriting discounts, commissions and offering expenses, totaled $782.3 million. All of the net proceeds of the IPO were used to settle pre-existing obligations to the Company's former parent, BMS.

        On November 15, 2009, BMS announced an exchange offer whereby BMS shareholders could exchange a portion of BMS common stock for Mead Johnson Nutrition Company stock. The exchange offer was completed on December 23, 2009, resulting in the separation of Mead Johnson Nutrition Company and the disposal of BMS's entire ownership and voting interest.

        Expensed transaction costs for the IPO recorded within selling, general, and administrative expense for the year ended December 31, 2009 were $31.0 million.